Evolent Health (NYSE: EVH) reported Q3 EPS of ($0.16), $0.05 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $40.4 million versus the consensus estimate of $42.51 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.